recombinant 70-kD heat-shock protein

also known as HSP70

today NCT00030303 · Ph 1

200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT00030303	Jan 2001 → Jan 2004	leukemia	UConn Health	Completed	No outcome recorded

Also used as a comparator or background therapy in 1 trial

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT00005633 Background	Jun 1999 → Jun 2002	cutaneous melanoma	Memorial Sloan Kettering Cancer Center	Completed	No outcome recorded

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	recombinant 70-kD heat-shock protein	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00030303 ↗ 1 NCT00005633 ↗
Known as	HSP70	“heat shock protein 70 (HSP70)” NCT00005633 ↗
Modality	Protein / enzyme biologic	“heat shock protein 70 (HSP70)” NCT00005633 ↗
Route	Subcutaneous	“subcutaneously” NCT00005633 ↗